# John Su

**Type:** Researchers  
**Canonical URL:** https://scholariq.org/researchers/john-su/

## Facts

| Field | Value |
| --- | --- |
| Citations | 4,590 |
| Field | Dermatology and Skin Diseases |
| h-index | 35 |
| i10-index | 58 |
| Last Known Institution | Royal Children's Hospital |
| OpenAlex ID | https://openalex.org/A5016684695 |
| ORCID iD | 0000-0002-4021-5423 |
| Works | 120 |

## Researcher papers

- [A Randomized, Controlled Trial of Oral Propranolol in Infantile Hemangioma](https://scholariq.org/papers/a-randomized-controlled-trial-of-oral-propranolol-in-infantile-hemangioma/)
- [Atopic eczema: its impact on the family and financial cost](https://scholariq.org/papers/atopic-eczema-its-impact-on-the-family-and-financial-cost/)
- [When does atopic dermatitis warrant systemic therapy? Recommendations from an expert panel of the International Eczema Council](https://scholariq.org/papers/when-does-atopic-dermatitis-warrant-systemic-therapy-recommendations-from-an/)
- [The role of bacterial skin infections in atopic dermatitis: expert statement and review from the International Eczema Council Skin Infection Group](https://scholariq.org/papers/the-role-of-bacterial-skin-infections-in-atopic-dermatitis-expert-statement-and/)
- [Artificial Intelligence in Dermatology—Where We Are and the Way to the Future: A Review](https://scholariq.org/papers/artificial-intelligence-in-dermatology-where-we-are-and-the-way-to-the-future-a/)
- [A randomized trial of a barrier lipid replacement strategy for the prevention of atopic dermatitis and allergic sensitization: the <scp>PEBBLES</scp> pilot study](https://scholariq.org/papers/a-randomized-trial-of-a-barrier-lipid-replacement-strategy-for-the-prevention-of/)
- [The skin as a target for prevention of the atopic march](https://scholariq.org/papers/the-skin-as-a-target-for-prevention-of-the-atopic-march/)
- [CARD14-associated papulosquamous eruption: A spectrum including features of psoriasis and pityriasis rubra pilaris](https://scholariq.org/papers/card14-associated-papulosquamous-eruption-a-spectrum-including-features-of/)
- [Mosaic Activating Mutations in FGFR1 Cause Encephalocraniocutaneous Lipomatosis](https://scholariq.org/papers/mosaic-activating-mutations-in-fgfr1-cause-encephalocraniocutaneous-lipomatosis/)
- [Female-Specific Downregulation of Tissue Polymorphonuclear Neutrophils Drives Impaired Regulatory T Cell and Amplified Effector T Cell Responses in Autoimmune Dry Eye Disease](https://scholariq.org/papers/female-specific-downregulation-of-tissue-polymorphonuclear-neutrophils-drives/)
- [Characteristics, Disease Burden and Healthcare Resource Use of Moderate and Severe Atopic Dermatitis in Australia](https://scholariq.org/papers/characteristics-disease-burden-and-healthcare-resource-use-of-moderate-and/)

## Researcher topics

- [Dermatology and Skin Diseases](https://scholariq.org/topics/dermatology-and-skin-diseases/)
- [Allergic Rhinitis and Sensitization](https://scholariq.org/topics/allergic-rhinitis-and-sensitization/)
- [Asthma and respiratory diseases](https://scholariq.org/topics/asthma-and-respiratory-diseases/)
- [Food Allergy and Anaphylaxis Research](https://scholariq.org/topics/food-allergy-and-anaphylaxis-research/)
- [Autoimmune Bullous Skin Diseases](https://scholariq.org/topics/autoimmune-bullous-skin-diseases/)

## Researcher university

- [Royal Children's Hospital](https://scholariq.org/institutions/royal-children-s-hospital/)

---
Source: ScholarIQ — public research metadata, principally OpenAlex. See https://scholariq.org/sources/ for provenance and https://scholariq.org/methodology/ for what these figures mean.